Earth Science Tech, Inc. (OTCMKTS:ETST) CEO Giorgio R. Saumat recently purchased shares of the company's stock, according to a recent filing with the Securities and Exchange Commission. Saumat, who also serves as a director and a ten percent owner of the company, acquired a total of $12,071 worth of common stock on the open market.
The transactions, all executed on October 10, 2024, involved buying shares at prices ranging from $0.15 to $0.1697. This series of purchases is indicative of Saumat's growing stake in the pharmaceutical preparations company. Following these acquisitions, the CEO now owns 121,516,682 shares of Earth Science Tech.
Investors often look to insider buying as a positive signal that company executives are confident in the firm's future prospects. The recent purchases by Saumat could be interpreted as a commitment to the company's success and a belief in its value.
Earth Science Tech, based in Miami, Florida, operates in the pharmaceutical sector and is known for its specialized preparations. The company, which was formerly known as Ultimate Novelty Sports Inc., has a fiscal year that ends on March 31.
For those tracking insider transactions, the details of Saumat's purchases provide a glimpse into executive actions that can influence investor sentiment. The disclosure of such transactions helps ensure transparency in the market and allows shareholders to stay informed about the financial dealings of company insiders.
In other recent news, Earth Science Tech, Inc., a Florida-based biotechnology company, has announced significant developments in its business operations. The company recently completed two strategic acquisitions, purchasing Avenvi, LLC, a real estate holding entity, and Mister Meds, LLC, a Texas-based firm. Alongside these acquisitions, Earth Science Tech launched a new brand, Zoolzy, venturing into the pet and wildlife industry.
The company also relocated its principal office in Miami, FL, adding approximately 1,125 square feet to its existing space. Earth Science Tech repurchased 11,545,898 shares of its common stock as part of a $5 million repurchase program.
In terms of executive changes, Earth Science Tech disclosed new compensatory arrangements for CEO Giorgio R. Saumat and COO Mario G. Tabraue. The payout structure is contingent upon the company's net profit growing quarter over quarter. The company also announced that COO Mario G. Tabraue will step down from his positions within the company's wholly-owned subsidiaries to focus solely on his responsibilities as COO. These are the recent developments within the company.
InvestingPro Insights
Earth Science Tech, Inc. (ETST) has shown remarkable financial performance, aligning with CEO Giorgio R. Saumat's recent stock purchases. According to InvestingPro data, the company's revenue growth has been explosive, with a staggering 7,462.31% increase over the last twelve months as of Q1 2025. This exceptional growth is further emphasized by a quarterly revenue growth of 3,796.13% in Q1 2025.
The company's profitability metrics are equally impressive. ETST boasts a gross profit margin of 69.4% and an operating income margin of 13.29%, indicating efficient operations and strong pricing power in the pharmaceutical preparations market.
InvestingPro Tips highlight that ETST has a perfect Piotroski Score of 9, suggesting robust financial health and operational efficiency. This score aligns well with Saumat's decision to increase his stake in the company. Additionally, the company operates with a moderate level of debt, which is a positive sign for its financial stability.
The stock's performance has been noteworthy, with a 233.33% price total return over the past year. However, investors should note that ETST's stock price movements are quite volatile, as pointed out by another InvestingPro Tip.
For those interested in a deeper analysis, InvestingPro offers 7 additional tips for ETST, providing a comprehensive view of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.